ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

UC Davis Coordinates Asian American Network

September 27, 2002

Antman, Clanton begin work at NCI.

December 5, 2003

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Jordan Gutterman Selected To Head Lasker Awards Program

January 4, 1991

In Brief: Obey Was Right- Tests On 70 Chemical Would Have Been Aborted Under NCI Budget

July 20, 1979

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012